These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37345534)

  • 1. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.
    Nakamura T; Nishikawa Y; Shiokawa M; Takeda H; Yokode M; Matsumoto S; Muramoto Y; Ota S; Yoshida H; Okada H; Kuwada T; Marui S; Matsumori T; Maruno T; Uza N; Kodama Y; Hatano E; Seno H
    J Pathol; 2023 Sep; 261(1):28-42. PubMed ID: 37345534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
    Yang L; Wang H; Guo M; He M; Zhang W; Zhan M; Liu Y
    Cell Oncol (Dordr); 2023 Aug; 46(4):1085-1095. PubMed ID: 36988891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
    Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
    Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition.
    Zong H; Yin B; Zhou H; Cai D; Ma B; Xiang Y
    Mol Biol Rep; 2014 Jul; 41(7):4507-12. PubMed ID: 24623408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
    Liu S; Wang Y; Han Y; Xia W; Zhang L; Xu S; Ju H; Zhang X; Ren G; Liu L; Ye W; Zhang Z; Hu J
    Theranostics; 2020; 10(23):10589-10605. PubMed ID: 32929368
    [No Abstract]   [Full Text] [Related]  

  • 6. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
    Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
    Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of EREG/EGFR Pathway in Tumor Progression.
    Cheng WL; Feng PH; Lee KY; Chen KY; Sun WL; Van Hiep N; Luo CS; Wu SM
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
    Pandey A; Stawiski EW; Durinck S; Gowda H; Goldstein LD; Barbhuiya MA; Schröder MS; Sreenivasamurthy SK; Kim SW; Phalke S; Suryamohan K; Lee K; Chakraborty P; Kode V; Shi X; Chatterjee A; Datta K; Khan AA; Subbannayya T; Wang J; Chaudhuri S; Gupta S; Shrivastav BR; Jaiswal BS; Poojary SS; Bhunia S; Garcia P; Bizama C; Rosa L; Kwon W; Kim H; Han Y; Yadav TD; Ramprasad VL; Chaudhuri A; Modrusan Z; Roa JC; Tiwari PK; Jang JY; Seshagiri S
    Nat Commun; 2020 Aug; 11(1):4225. PubMed ID: 32839463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling.
    Yan X; Yang P; Liu H; Zhao Y; Wu Z; Zhang B
    Cell Cycle; 2022 Jun; 21(11):1166-1177. PubMed ID: 35196196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
    Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
    J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma.
    Liu S; Ye D; Xu D; Liao Y; Zhang L; Liu L; Yu W; Wang Y; He Y; Hu J; Guo W; Wang T; Sun B; Song H; Yin H; Liu J; Wu Y; Zhu H; Zhou BP; Deng J; Zhang Z
    Oncotarget; 2016 May; 7(18):25251-63. PubMed ID: 26958807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
    Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
    Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.
    Lyu WJ; Shu YJ; Liu YB; Dong P
    Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
    Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
    Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
    Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί.
    Lee JS; Choi YE; Kim S; Han JY; Goh SH
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer.
    Suzuki M; Saito-Adachi M; Arai Y; Fujiwara Y; Takai E; Shibata S; Seki M; Rokutan H; Maeda D; Horie M; Suzuki Y; Shibata T; Kiyono T; Yachida S
    Cancer Res; 2021 Jan; 81(2):489-500. PubMed ID: 33293429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
    Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.
    Gondkar K; Patel K; Krishnappa S; Patil A; Nair B; Sundaram GM; Zea TT; Kumar P
    Cancer Biomark; 2019; 25(2):223-232. PubMed ID: 31104013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.